Individual response
|
|
114
|
10856
|
May 17, 2022
|
Quality of remdesivir trials
|
|
51
|
8375
|
May 12, 2022
|
Canonical references for different types of "bias"
|
|
6
|
444
|
May 5, 2022
|
Validation of cox model
|
|
4
|
1669
|
May 2, 2022
|
Point estimator for nomogram in rmsb
|
|
1
|
199
|
April 26, 2022
|
Rmsb: Relative Explained Variation of Clustering Variable
|
|
6
|
379
|
April 20, 2022
|
Relative excess risk due to interaction (RERI) from a multiplicative model
|
|
3
|
363
|
April 20, 2022
|
RCT and "Mathematical Embellishment"
|
|
2
|
493
|
April 5, 2022
|
Article: Going from evidence to recommendations: Can GRADE get us there?
|
|
0
|
313
|
April 3, 2022
|
Chi-Squared for relative risk
|
|
1
|
361
|
March 27, 2022
|
Causal graph based on data generation process
|
|
3
|
474
|
February 22, 2022
|
Bayesian Re-Analysis of Clinical Trial Data
|
|
22
|
9523
|
January 27, 2022
|
AUC of each subgroup is smaller than overall AUC
|
|
2
|
2135
|
January 21, 2022
|
Comparing Marginal effects across sets of explanatory variables in the same model
|
|
9
|
1505
|
January 1, 2022
|
Catastrophic Heterogeneity Meets "The Clairvoyant RCT"
|
|
0
|
743
|
December 28, 2021
|
Nonparametric multiple linear regression (with interaction term and all !)
|
|
3
|
1142
|
December 18, 2021
|
Interpreting the random-effect solution in a mixed model
|
|
16
|
1912
|
December 18, 2021
|
Statistics Applied Using Threshold Science Fails to Deliver Progression Toward Truth
|
|
3
|
1443
|
December 14, 2021
|
How to achieve a pragmatic but correct interpretation of p values in null hypothesis significance testing framework NHST
|
|
1
|
901
|
November 28, 2021
|
Recommendations of good methods examples in the biomarker literature
|
|
4
|
930
|
November 23, 2021
|
Validity of comparing two different previously published cohort studies using IPTW for matching
|
|
5
|
994
|
November 11, 2021
|
Interpretation of the REGEN-COV trial
|
|
22
|
3127
|
November 1, 2021
|
Evidence Based Decision Making and Meta-Analysis -- An Information Theoretic Critique
|
|
0
|
1022
|
October 27, 2021
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
2
|
2855
|
September 22, 2021
|
Probability in state Ps(t) and Hazard ratio HR in Cox model
|
|
1
|
1115
|
August 21, 2021
|
Logit Rank Plot by J.Copas in rms R package
|
|
6
|
1271
|
August 20, 2021
|
Resources for Mixed-Effect Models in Medical Contexts
|
|
7
|
1445
|
August 8, 2021
|
Interactions and random error
|
|
15
|
3471
|
July 17, 2021
|
Question arising from JAMA Guide article "Odds Ratios—Current Best Practice and Use"
|
|
19
|
8364
|
July 13, 2021
|
Statistical Misinterpretations and Clinical Practice Guidelines: any examples?
|
|
31
|
4787
|
June 28, 2021
|